CARLSBAD, Calif.--(BUSINESS WIRE)--Apr 3, 2013--Advanced Brain Monitoring , Inc., a medical device company focused on improving healthcare for patients suffering from sleep and neurological disorders, announced today the launch of InsomniCare SM, an integrated cloud-based system, used at home, designed to help millions of insomnia sufferers improve their overall wellness, and workplace productivity and safety.
Sleep Profiler(TM) is now available for home use through your doctor. (Photo: Business Wire) “ Sleep Profiler TM assists clinicians in identifying patients who will likely benefit from CBT-I and those who may have an underlying medical condition causing the insomnia symptoms that requires further evaluation,” stated Dr. Philip R. Westbrook, Chief Medical Officer, Advanced Brain Monitoring, and Past-President, American Academy of Sleep Medicine. InsomniCare SM helps clinicians improve the treatment of their patients while complying with the recent FDA drug safety warning to lower the daily dosage of Ambien and similar insomnia drugs by 50% in order to reduce the risk of next-morning impairment.
“Cognitive Behavioral Therapy for Insomnia (CBT-I) is considered the first choice for treatment of chronic insomnia,” explained Dr. Michael T. Smith, Co-Director, Johns Hopkins Center for Sleep-Related Symptom Science and President of the Society of Behavioral Sleep Medicine. “Web-based CBT-I allows patients to learn how to change sleep behaviors which contribute to insomnia without having to take time off for treatment. Sleep Profiler TM allows clinicians to apply a stepped-approach to identify the many patients who will be effectively treated with online CBT-I and recognize those who may need to be referred to a qualified behavioral sleep medicine specialist.” InsomniCare SM is an integrated program that includes a web-based screening questionnaire to characterize the severity of an individual’s perceived insomnia symptoms. A Sleep Profiler TM study is then conducted in the comfort of the patient’s home. Sleep Profiler TM is a non-intrusive, user-friendly, patented technology cleared by the FDA for the neurological and cardiovascular assessment of sleep quality. The sleep study data are reviewed by a sleep medicine specialist after upload and, when recommended, web-based Cognitive Behavioral Therapy for Insomnia (CBT-I) is ordered through the integrated web-portal. The portal allows for on-going clinician monitoring of progress, and concludes with a follow-up Sleep Profiler TM study to confirm that the patient’s sleep patterns are in the normal range.
“InsomniCare SM is a significant advancement in the management of insomnia,” stated Daniel J. Levendowski, President of Advanced Brain Monitoring. “It improves quality-of-care by providing clinicians a cost-effective means to confirm the patient’s sleep complaints with an objective assessment of sleep quality. Our scientifically validated CBT-I program addresses an important gap in provider coverage resulting from a shortage of qualified behavioral sleep therapists . Our cloud-based, integrated system now enables insomnia assessment and treatment to be delivered nationwide in a Medical Home Model.” Insomnia is a chronic disorder for patients who experience difficulty initiating or maintaining sleep, or suffer from non-restorative sleep for at least one month; 37% of U.S. adults report having insomnia or sleep difficulties. The average annual direct and indirect healthcare costs for individuals with insomnia are $4,600 greater than good sleepers. Patients with insomnia are associated with over 7% of all costly workplace accidents and the average cost of insomnia-related accidents and errors are one-third greater than the other sources of accidents/errors.
About Advanced Brain Monitoring
Advanced Brain Monitoring, headquartered in Carlsbad, CA, is a privately-held industry leader focused on developing innovative solutions for the diagnosis and treatment of sleep, neurological, and psychiatric disorders. Sleep Profiler TM is a patented technology developed by the inventors of the ARES TM, the world’s most widely-used home sleep test for the diagnosis of obstructive sleep apnea. The Company has been named to the Inc. 5000 fastest growing U.S. companies for five consecutive years.
CARLSBAD, Calif.--(BUSINESS WIRE)--Apr 3, 2013--Advanced Brain Monitoring, Inc., a medical device company focused on improving healthcare for patients suffering from sleep and neurological disorders, announced today the launch of InsomniCare SM, an integrated cloud-based system, used at home,...